Crinetics Pharmaceuticals, Inc. earnings per share and revenue

CRNX earnings per share for the last quarter are -0.88 USD whereas the estimation was -0.89 USD which accounts for 0.69% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 723.73 k USD. Estimated earnings per share for the next quarter are -0.92 USD, and revenue is expected to reach 137.50 k USD. Also watch annual changes over time to get a bigger picture of CRNX earnings per share and revenue dynamics.